Researchers and investigators escalated concerns over antibody validation images after they found apparent manipulation in vendor-supplied western blot data. A dispute over what Thermo Fisher did to the images sparked public outcry, with a growing catalog documenting hundreds of suspect validation images and researchers expressing reluctance to purchase affected products.